Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies

Mitragotri, Samir, Burke, Paul A., Langer, Robert·2014·Nature Reviews Drug Discovery
DOI 10.1038/nrd4363

Cites (205)

Items 201–205 of 205

  1. Octreotide fluid crystal provides sustained octreotide bioavailability and similar IGF1 suppression to that of octreotide LAR (Sandostatin LAR): randomized, open-label, Phase I, repeat-dose study in healthy volunteers
    John Roberts, Margareta Linden, Camilla Cervin, Fredrik Tiberg · 2014 · Endocrine Abstracts
  2. Chiasma and Roche partner in oral peptide drug delivery
    Charlotte Harrison · 2013 · Nature Reviews Drug Discovery
  3. Engineering Approaches to Transdermal Drug Delivery: A Tribute to Contributions of Prof. Robert Langer
    Samir Mitragotri · 2013 · Skin Pharmacology and Physiology
  4. Abstract P6-11-05: ANG4043, a brain-penetrant anti-HER2 mAb increases survival in mice bearing intracranial BT-474 breast tumor cells
    Jean E. Lachowicz, Michel Demeule, Anthony Régina, Emilie Houle, Sasmita Tripathy, J. Castaigne · 2013 · Cancer Research
  5. Pharmacokinetics (PK) and immunologic responses in a phase I/II study of a sustained release formulation of IL-2 in renal cell carcinoma (RCC) patients
    Stéphane Marie. Oudard, Nicolas Thiounn, Wolf H. Fridman, Delphine Amsellem‐Ouazana, Marc C. Colombel, Didier Jacqmin D, Bernard A. Malavaud, Roger Kravtzoff · 2006 · Journal of Clinical Oncology